CTAGX | VISGX | CTAGX / VISGX | |
Total Expense Ratio | 1.35 | 0.19 | 711% |
Annual Report Gross Expense Ratio | 1.81 | 0.19 | 953% |
Fund Existence | 6 years | 27 years | - |
Gain YTD | 10.668 | 4.750 | 225% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 34.8M | 37.5B | 0% |
Annual Yield % from dividends | 2.24 | 0.40 | 558% |
Returns for 1 year | 23.99 | 12.34 | 194% |
Returns for 3 years | 64.75 | 39.84 | 163% |
Returns for 5 years | 42.15 | 37.89 | 111% |
Returns for 10 years | N/A | 143.30 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LFSC | 28.12 | 0.25 | +0.89% |
F/m Emerald Life Sciences Innovation ETF | |||
FNK | 55.81 | -0.21 | -0.37% |
First Trust Mid Cap Value AlphaDEX® ETF | |||
MBB | 93.65 | -0.36 | -0.38% |
iShares MBS ETF | |||
OUSA | 55.81 | -0.23 | -0.40% |
ALPS O'Shares US Quality Div ETF | |||
DISO | 13.28 | -0.08 | -0.57% |
YieldMax DIS Option Income Strategy ETF |